Not available
Quote | Sage Therapeutics Inc. (NASDAQ:SAGE)
Last: | $12.80 |
---|---|
Change Percent: | -0.81% |
Open: | $12.39 |
Close: | $12.80 |
High: | $12.81 |
Low: | $12.24 |
Volume: | 804,944 |
Last Trade Date Time: | 07/22/2024 03:00:00 am |
News | Sage Therapeutics Inc. (NASDAQ:SAGE)
Sage Therapeutics, Inc. (NASDAQ: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, today announced that it will host a live webcast on Wednesday, July 31, 2024 at 4:30 p.m. ET to review second quarter 2024 financial results and discuss recent business ...
2024-06-20 13:15:04 ET Scotiabank analyst issues UNDERPERFORM recommendation for SAGE on June 20, 2024 10:00AM ET. The previous analyst recommendation was Underperform. SAGE was trading at $10.525 at issue of the analyst recommendation. The overall analyst consensus : HO...
Message Board Posts | Sage Therapeutics Inc. (NASDAQ:SAGE)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $SAGE News Article - "Buzz on the Street" Show: Sage Potash Corp. (TSX-V: SAGE) Expansi | whytestocks | investorshangout | 04/11/2023 8:35:50 PM |
whytestocks: $SAGE News Article - Breaking News: SAGE POTASH CORP. ANNOUNCES EXPANSION OF LAND PACKA | whytestocks | investorshangout | 04/11/2023 5:25:51 PM |
whytestocks: $SAGE News Article - Sage Therapeutics and Biogen Announce FDA Accepts Filing of New Dr | whytestocks | investorshangout | 02/06/2023 5:05:46 PM |
whytestocks: $SAGE News Article - Biogen and Sage Therapeutics Announce FDA Accepts Filing of New Dr | whytestocks | investorshangout | 02/06/2023 4:20:45 PM |
whytestocks: $SAGE News Article - Sage Therapeutics Announces Third Quarter 2022 Financial Results a | whytestocks | investorshangout | 11/08/2022 7:40:51 PM |
News, Short Squeeze, Breakout and More Instantly...
Sage Therapeutics Inc. Company Name:
SAGE Stock Symbol:
NASDAQ Market:
Sage Therapeutics Inc. Website:
Sage Therapeutics, Inc. (NASDAQ: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, today announced that it will host a live webcast on Wednesday, July 31, 2024 at 4:30 p.m. ET to review second quarter 2024 financial results and discuss recent business ...
2024-06-20 13:15:04 ET Scotiabank analyst issues UNDERPERFORM recommendation for SAGE on June 20, 2024 10:00AM ET. The previous analyst recommendation was Underperform. SAGE was trading at $10.525 at issue of the analyst recommendation. The overall analyst consensus : HO...
2024-06-20 13:15:04 ET Wedbush analyst issues SECTOR PERFORM recommendation for SAGE on June 20, 2024 10:00AM ET. The previous analyst recommendation was Sector Perform. SAGE was trading at $10.525 at issue of the analyst recommendation. The overall analyst consensus : H...